Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
Dr. Ayaaz Hussain Khan, Global Head of Generics at Navitas Life Sciences, will be a distinguished presence at CPHI 2023. With a wealth of experience and vast expertise, Dr. Khan will be present to find solutions for your unique needs and to provide a glimpse into the future of generics. In this blog, we spoke to Dr. Khan, to ask what CPHI North Bar...
Navitas Life Sciences will showcase as a strategic partner at the upcoming SCDM Live Annual Conference – The Festival of Clinical Data Science, between 08 - 11 October 2023 in the Hilton San Diego Bayfront, San Diego, CA, USA. Our team of experts will be present to discuss insights that will transform your Clinical Data landscape. In this bl...
Navitas Life Sciences, a trusted global CRO, will be participating in the highly anticipated World Drug Safety Congress events in both America and Europe. With a legacy of excellence in pharmacovigilance, we will be present to discuss how we can support your PV needs with our expert insights and vast experience. Elevating Drug Safety Through Expert...
Celebrating a New Milestone: 100,000 Potency Batches without any Issue We are proud and happy to announce a significant milestone in our journey towards excellence and efficiency in supporting Aurobindo Pharmaceuticals, a global pharmaceutical manufacturing company. Recently, we marked the successful reach of 100,000 potency calculated batches thro...
The Regulatory Affairs Professionals Society (RAPS) Convergence is a pivotal event for regulatory professionals worldwide. As we approach the highly anticipated conference, Navitas Life Sciences, a global leader in regulatory and clinical services, is gearing up to discuss its vast experience and dedication to innovation. We had the privilege of si...
Navitas Life Sciences has been supporting efficient clinical trials for over 30 years to bring life-saving drugs to the market sooner. Patient centricity has been at the heart of our clinical trials, as it is important to align with the needs and wants of patients to improve patient engagement during the trial. According to a study, 86% of clinical...
The adoption of environmental, social, and governance (ESG) strategies presents opportunities for sustainable and inclusive growth. Incorporating ESG strategies not only enhances societal, and environmental impact but also ensures long-term competitiveness. Our approach to ESG amalgamates our deep understanding of the factors driving value and impa...
The pharmaceutical industry is undergoing constant reshaping with automation, cognitive intelligence, and other technological advancements being developed to ensure patient safety. Pharmacovigilance plays a crucial role in identifying, assessing, and preventing adverse effects of medications. At, Navitas Life Sciences, our comprehensive Pharmacovig...
Amidst rising disease burden, geopolitical instability, and the lasting impact of the COVID-19 pandemic, the pharma industry worldwide is grappling with transformations that have profound implications for their processes and protocols. These shifts encompass crucial decisions to foster resilience through increased speed, striking a balance between ...
In today's data-driven world, the life sciences industry is experiencing advances that are increasingly complex, with the need to extract meaningful insights from vast amounts of clinical data. Navitas Life Sciences, a leading technology driven clinical trials partner, stands at the forefront of this revolution, offering comprehensive clinical data...